Rosario Menendez

Summary

Country: Spain

Publications

  1. ncbi Stability in community-acquired pneumonia: one step forward with markers?
    R Menendez
    Servicio de Neumologia, Universitary Hospital La Fe, Ciber de enfermedades respiratorias CIBERES, Valencia, Spain
    Thorax 64:987-92. 2009
  2. ncbi Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia
    R Menendez
    Servicio de Neumologia, Universitary Hospital La Fe, Ciber de enfermedades respiratorias CIBERES, Avda de Campanar 21, 46009 Valencia, Spain
    Thorax 64:587-91. 2009
  3. ncbi Markers of treatment failure in hospitalised community acquired pneumonia
    R Menendez
    Servicio de Neumologia, Hospital Universitario La Fe, Avda de Campanar 21, 46009 Valencia, Spain
    Thorax 63:447-52. 2008
  4. ncbi Treatment failure in community-acquired pneumonia
    Rosario Menendez
    Servicio de Neumologia, Hospital Universitario La Fe, Avda de Campanar 21, 46009 Valencia, Spain
    Chest 132:1348-55. 2007
  5. ncbi Economic evaluation of adherence to treatment guidelines in nonintensive care pneumonia
    R Menendez
    Pneumology Service, La Fe University Hospital, 46009 Valencia, Spain
    Eur Respir J 29:751-6. 2007
  6. ncbi Guidelines for the treatment of community-acquired pneumonia: predictors of adherence and outcome
    Rosario Menendez
    Servicio de Neumologia, Hospital Universitario La Fe, Avda de Campanar 21, 46009 Valencia, Spain
    Am J Respir Crit Care Med 172:757-62. 2005
  7. ncbi Reaching stability in community-acquired pneumonia: the effects of the severity of disease, treatment, and the characteristics of patients
    Rosario Menendez
    Servicio de Neumologia, Hospital Universitario La Fe, Valencia, Spain
    Clin Infect Dis 39:1783-90. 2004
  8. pmc Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome
    R Menendez
    Servicio de Neumologia, Hospital Universitario La Fe, Valencia, Spain
    Thorax 59:960-5. 2004
  9. ncbi Duration of length of stay in pneumonia: influence of clinical factors and hospital type
    R Menendez
    Pneumology Service of the Hospital Universitario La Fe, Valencia, Spain
    Eur Respir J 22:643-8. 2003
  10. doi Initial management of pneumonia and sepsis: factors associated with improved outcome
    R Menendez
    Servicio de Neumologia, Hospital Universitario i Politèctic Butevar sur s n, 46026 Valencia, Spain
    Eur Respir J 39:156-62. 2012

Detail Information

Publications22

  1. ncbi Stability in community-acquired pneumonia: one step forward with markers?
    R Menendez
    Servicio de Neumologia, Universitary Hospital La Fe, Ciber de enfermedades respiratorias CIBERES, Valencia, Spain
    Thorax 64:987-92. 2009
    ..The objective of this study was to evaluate whether the biological markers procalcitonin (PCT) and C-reactive protein (CRP) might reflect stability after 72 h of treatment and the absence of subsequent severe complications...
  2. ncbi Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia
    R Menendez
    Servicio de Neumologia, Universitary Hospital La Fe, Ciber de enfermedades respiratorias CIBERES, Avda de Campanar 21, 46009 Valencia, Spain
    Thorax 64:587-91. 2009
    ..Prognostic scales provide a useful tool to predict mortality in community-acquired pneumonia (CAP). However, the inflammatory response of the host, crucial in resolution and outcome, is not included in the prognostic scales...
  3. ncbi Markers of treatment failure in hospitalised community acquired pneumonia
    R Menendez
    Servicio de Neumologia, Hospital Universitario La Fe, Avda de Campanar 21, 46009 Valencia, Spain
    Thorax 63:447-52. 2008
    ..We evaluated the systemic cytokine profile (tumour necrosis factor alpha, interleukin (IL)1, IL6, IL8 and IL10), C reactive protein (CRP) and procalcitonin (PCT) in patients with CAP who had treatment failure...
  4. ncbi Treatment failure in community-acquired pneumonia
    Rosario Menendez
    Servicio de Neumologia, Hospital Universitario La Fe, Avda de Campanar 21, 46009 Valencia, Spain
    Chest 132:1348-55. 2007
    ..The diagnostic yield of imaging procedures with noninvasive and invasive samples is up to 70%. After obtaining microbiological samples, an empirical change in antibiotic therapy is required to cover a wider microbial spectrum...
  5. ncbi Economic evaluation of adherence to treatment guidelines in nonintensive care pneumonia
    R Menendez
    Pneumology Service, La Fe University Hospital, 46009 Valencia, Spain
    Eur Respir J 29:751-6. 2007
    ..The sensitivity analysis demonstrated that the findings were robust. An antimicrobial treatment according to guidelines is the dominant alternative due to its cost-effectiveness...
  6. ncbi Guidelines for the treatment of community-acquired pneumonia: predictors of adherence and outcome
    Rosario Menendez
    Servicio de Neumologia, Hospital Universitario La Fe, Avda de Campanar 21, 46009 Valencia, Spain
    Am J Respir Crit Care Med 172:757-62. 2005
    ..Some studies highlight the association of better clinical responses with adherence to guidelines for empiric treatment of community-acquired pneumonia (CAP), but little is known about factors that influence this adherence...
  7. ncbi Reaching stability in community-acquired pneumonia: the effects of the severity of disease, treatment, and the characteristics of patients
    Rosario Menendez
    Servicio de Neumologia, Hospital Universitario La Fe, Valencia, Spain
    Clin Infect Dis 39:1783-90. 2004
    ..The aim of our study was to identify those factors related to host characteristics, the severity of pneumonia, and treatment that influence clinical stability...
  8. pmc Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome
    R Menendez
    Servicio de Neumologia, Hospital Universitario La Fe, Valencia, Spain
    Thorax 59:960-5. 2004
    ..A study was undertaken to quantify the incidence of failure of empirical treatment in CAP, to identify risk factors for treatment failure, and to determine the implications of treatment failure on the outcome...
  9. ncbi Duration of length of stay in pneumonia: influence of clinical factors and hospital type
    R Menendez
    Pneumology Service of the Hospital Universitario La Fe, Valencia, Spain
    Eur Respir J 22:643-8. 2003
    ....
  10. doi Initial management of pneumonia and sepsis: factors associated with improved outcome
    R Menendez
    Servicio de Neumologia, Hospital Universitario i Politèctic Butevar sur s n, 46026 Valencia, Spain
    Eur Respir J 39:156-62. 2012
    ..In sepsis, antibiotic adherence is the strongest protective factor of care associated with survival and LOS. In severe sepsis, combined antibiotic adherence and first dose within 6 h may reduce mortality...
  11. doi Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia
    Paula Ramirez
    Unidad de Cuidados Intensivos and Servicio de Neumologia, Hospital Universitario La Fe, Valencia, Spain
    Crit Care Med 39:2211-7. 2011
    ..We assessed the relationship between inflammatory response, prediction for intensive care unit admission, delayed intensive care unit admission, and outcome in patients with community-acquired pneumonia...
  12. pmc Compliance with guidelines-recommended processes in pneumonia: impact of health status and initial signs
    Rosario Menendez
    Servicio de Neumologia, Hospital Universitario y Politécnico La Fe, CibeRes, Valencia, Spain
    PLoS ONE 7:e37570. 2012
    ..Deficient health status and confusion, rather than age, are associated with lower compliance with antibiotic therapy recommendations and timing, thus identifying a subpopulation more prone to receiving lower quality care...
  13. ncbi Cytokine activation patterns and biomarkers are influenced by microorganisms in community-acquired pneumonia
    Rosario Menendez
    Department of Pneumology, Hospital Universitari I Politècnic La Fe, Bulevar Sur S N, 46026 Valencia, Spain
    Chest 141:1537-45. 2012
    ..Here, we analyze the patterns of inflammatory cytokines, procalcitonin (PCT), and C-reactive protein (CRP) in order to determine their diagnostic value...
  14. doi Impact of guidelines on outcome: the evidence
    Raquel Martinez
    Servicio de Neumologia, Hospital Universitario La Fe, Valencia, Valencia, Spain
    Semin Respir Crit Care Med 30:172-8. 2009
    ..Finally, the choice of antibiotics that adhere to the guidelines is cost-effective in CAP requiring hospitalization, which is responsible for 80% of the total cost of this disease...
  15. ncbi Influence of deviation from guidelines on the outcome of community-acquired pneumonia
    Rosario Menendez
    Pneumology Service, University Hospital La Fe, Valencia, Spain
    Chest 122:612-7. 2002
    ....
  16. ncbi Evaluation of nonresolving and progressive pneumonia
    Rosario Menendez
    Servicio de Neumologia, Hospital Universitario La Fe, Valencia, Spain
    Semin Respir Infect 18:103-11. 2003
    ..Empiric therapeutic changes are aimed at broadening bacteriologic coverage to treat resistant or unusual microorganisms...
  17. pmc Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in patients with acute respiratory distress syndrome and abdominal diseases: a preliminary observational study
    Paula Ramirez
    Department of Intensive Care Medicine, Hospital Universitario La Fe, Avda, Campanar 21, 46009 Valencia, Spain
    Crit Care 15:R50. 2011
    ..For this purpose, we measured soluble triggering receptor expression on myeloid cells-1 (sTREM-1) in alveolar and peritoneal fluid...
  18. ncbi Inflammatory response in mixed viral-bacterial community-acquired pneumonia
    Salvador Bello
    Servicio de Neumologia, Hospital Universitario Miguel Servet, Paseo Isabel la católica, 1 3, 50009 Zaragoza, Spain
    BMC Pulm Med 14:123. 2014
    ..We wanted to investigate this profile of mixed viral-bacterial infection and to compare it to monomicrobial bacterial or viral CAP...
  19. doi Prognostic power of proadrenomedullin in community-acquired pneumonia is independent of aetiology
    Salvador Bello
    Servicio de Neumologia, Hospital Universitario Miguel Servet, Zaragoza, Spain
    Eur Respir J 39:1144-55. 2012
    ..MR-proADM has high short- and long-term prognostic accuracy, and increases the accuracy of clinical scores. The prognostic value of MR-proADM is not modified by different possible CAP aetiologies...
  20. doi Systemic inflammatory response and increased risk for ventilator-associated pneumonia: a preliminary study
    Paula Ramirez
    Unidad de Cuidados Intensivos, Hospital Universitario La Fe, Valencia, Spain
    Crit Care Med 37:1691-5. 2009
    ..We prospectively assessed the evolution of cytokines in mechanically ventilated patients and their predictive and diagnostic role for VAP...
  21. doi Increased lung neutrophil apoptosis and inflammation resolution in nonresponding pneumonia
    I Moret
    Pharmacology Dept, School of Medicine, University and Politecnic Hospital La Fe, Bulevar Sur, 46026 Valencia, Spain
    Eur Respir J 38:1158-64. 2011
    ..After 72 h of treatment, an increased basal alveolar neutrophil apoptosis might contribute to downregulation of inflammation and to faster clinical stability...
  22. ncbi A worldwide perspective of atypical pathogens in community-acquired pneumonia
    Forest W Arnold
    Division of Infectious Diseases, University of Louisville, Louisville, KY 40292, USA
    Am J Respir Crit Care Med 175:1086-93. 2007
    ..In different regions of the world, monotherapy with a beta-lactam antimicrobial is common...